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Palytoxin (PTX) caused K+ release from rabbit erythrocytes which was dependent on the concentrations 
of extracellular Caz+ and PTX. In a Ca2+-free solution, PTX still caused aslow K+ release. An intracellular 
Ca*+ antagonist, TMB-8, an intracellular Ca 2+ chelator, quin 2, and calmodulin inhibitors, prenylamine, 
W-7 and W-5, inhibited the PTX-induced K+ release in a Ca2+-free solution. These results uggest that the 
PTX-induced K+ release isdependent on the process including intracellular Ca2+ and calmodulin. 
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1. INTRODUCTION 
Palytoxin (PTX), isolated from marine 
coelenterates of the genus Pulythoa, is one of the 
most poisonous animal toxins [l]. It has been 
reported that PTX increases K+ efflux and Na+ in- 
flux in erythrocytes, smooth muscle and 
pheochromocytoma cells [2-51. In the preceding 
paper, we suggested that the PTX-induced K+ 
release from erythrocytes is mediated by a 
Ca’+-calmodulin system [6]. Since Chhatwal et al. 
[7] suggested that external Ca” is not essential for 
the PTX-induced K+ release, we examined the role 
of intracellular Ca2+ on the PTX-induced K+ 
release from rabbit erythrocytes using an in- 
tracellular Ca antagonist, TMB 8 (81, an in- 
tracellular Ca chelator, quin 2 [9], and calmodulin 
inhibitors, prenylamine [lo], W-7 and W-5 [ll]. 
2. MATERIALS AND METHODS 
Rabbit erythrocytes were prepared as reported in 
[5]. Loss of K+ from erythrocytes was continuous- 
ly determined at 37’C using a K+-selective elec- 
trode (Philips, IS 561 K). Since calmodulin in- 
hibitors changed the sensitivity of the K+-selective 
electrode, erythrocytes tested with these com- 
pounds were incubated with PTX for 18 min at 
37”C, the reaction was stopped by a 2 min cen- 
trifugation at 650 x g at 25°C and the K+ content 
of the supernatant was measured with a Hitachi 
type 208 flame photometer. The amount of max- 
imum releasable K+ was determined by adding 
saponin (10m5 g/ml) at the end of each experiment. 
Physiological salt solution (PSS) contained (mM): 
136.9 NaCI, 1.0 CaClz, 1 .O MgClz, 5.5 glucose and 
10 Hepes at pH 7.4. Ca’+-free solution (below 5 x 
10m7 M Ca2+) was made by adding EGTA. 
PTX isolated from P. tuberculosa (kindly 
donated by Dr Y. Hirata, Meijo University, 
Nagoya) was dissolved in a solution containing 
0.1% bovine serum albumin and 2 mM Hepes (pH 
7.0) at 10m4 M, stored at -20°C and diluted just 
before use. 2-[(ZBis[carboxymethyl]aminoJ-me- 
thylphenoxy)methyl]-6-methoxy-8-bis[carboxyme- 
thyl]aminoquinolinetetrakis[acetoxymethyl] ester 
(quin 2-AM, Sigma) and prenylamine (Hoechst) 
were dissolved in dimethyl sulfoxide (DMSO). 
Nigericin (Calbiochem) was dissolved in ethanol. 
8-(N,ZV-Diethylamino)octyl 3,4,5_trimethoxyben- 
zoate (TMB-8, generous gifts from Tanabe), 
N-(6-aminohexyl)-5-chloro- 1 -naphthalenesulfon- 
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Fig.1. PTX-induced K+ release in the presence or absence of extracellular Ca2+. PTX was added after a 10 min 
preincubation period at 37°C in the presence of 10e3 M Ca2+ (A) or in the absence of Ca2+ (B). K+ release was measured 
with a K+-selective electrode. Abscissa, time (min); ordinate, K+ content in erythrocytes (olo). 100% represents the 
amount of total releasable K+ measured by the addition of lo-’ g/ml saponin. 
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Fig.2. Effects of TMB-8 and quin 2-AM on the PTX-induced K+ release in a Ca2+ -free solution. (A) 10e4 M TMB-8 
was added 10 min before the application of 10m9 M PTX. (B) Erythrocytes were preincubated with a Ca2+-free solution 
containing 10m4 M quin 2-AM at 37°C for 1 h, washed 3 times with a Ca 2+-free solution and then 10m9 M PTX was 
applied. In the control experiment, erythrocytes were treated with 1% DMSO alone. Abscissa, time (min); ordinate, 
K+ content in erythrocytes (olo). 
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amide (W-7), N-(6-aminohexyl)-l-naphthalenesul- 
fonamide (W-5) (both from Rikaken) and saponin 
(ICN) were dissolved in PSS. 
3. RESULTS 
PTX caused K+ release from erythrocytes in the 
presence of 10V3 M Ca2+ (fig.lA). The rate con- 
stants of K+ release due to lo-“, lo-’ and 10m8 M 
PTX were 0.21, 0.66 and 2.34 min-‘, respectively. 
The rate of K+ release was markedly retarded in a 
Ca’+-free solution (fig. 1B); the rate constants due 
to lo-lo, lo-’ and lo-’ M PTX were 0.0075, 0.17 
and 0.36 min-‘, respectively. In contrasts, the 
rates of K+ release induced by saponin ( 10e5 g/ml) 
and nigericin (lo-’ M) were independent of ex- 
tracellular Ca2+ concentrations (not shown). 
Fig.2 shows the effects of TMB-8 (low4 M) and 
quin 2-AM (10m4 M) on the rate of K+ release in- 
duced by PTX (lo-’ M) in a Ca’+-free solution. 
Although the control rate constants were slightly 
different, both TMB-8 and quin 2-AM decreased 
them to 56.8 and 51.79’0, respectively. 
Fig.3 shows the effects of prenylamine, W-7 and 
W-5 in a Ca2+-free solution. The K+ release due to 
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Fig.3. Inhibitory effects of prenylamine, W-7 and W-S 
on the PTX-induced K+ release in the absence of 
extracellular Ca”. Erythrocytes were preincubated for 
10 min with a Ca*+-free solution with or without 3 x 
lo-’ M prenylamine, low4 M W-7 or 10e4 M W-5. The 
amount of K+ released during a 20 min PTX incubation 
period was measured by flame photometry. Mean +- SE 
of 4 experiments is shown. 
PTX (lo-’ M) was inhibited to 10.6% by 
prenylamine, 13.3% by W-7 and 66.6% by W-5. 
4. DISCUSSION 
In the present experiment, we confirmed the 
result by Chhatwal et al. [7] that the PTX-induced 
K+ release is not completely inhibited in the 
absence of extracellular Ca2+. However, this result 
does not necessarily indicate that Ca2+ is not in- 
volved in the effect of PTX since cellular bound 
Ca2+ in erythrocytes is resistant o the incubation 
with a Ca2+-free solution [12]. In fact, the PTX- 
induced K+ release in a Ca2+-free solution was in- 
hibited by an intracellular Ca antagonist, TMB-8, 
and an intracellular Ca2+ chelator, quin 2. Further, 
the calmodulin inhibitors, prenylamine and W-7, 
inhibited the PTX-induced K+ release in the 
absence of extracellular Ca2+ whereas W-5, an 
analog of W-7 with lower affinity to calmodulin 
[ 111, showed smaller inhibition. Similar inhibitory 
potencies of these calmodulin inhibitors were 
reported in the presence of extracellular Ca2+ [6]. 
These results suggest hat PTX mobilizes cellular 
bound Ca2+ and activates a Ca’+-calmodulin 
system to induce K+ release from rabbit 
erythrocytes. 
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